Series D extends runway into 2027, advancing first-in-class c-mod DPTX3186 toward proof-of-concept in gastric cancer.Strong ...

Public and private investment serve different purposes. NIH funding often reduces scientific risk by advancing projects to a ...

AI-leveraged drug development has become an $18 billion industry, but companies in the sector are experiencing some hardships ...

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although clinical benefit ...